Product image of Meropenem Kalceks (Meropenem) supplied by GNH India

Meropenem Kalceks

Active Ingredient:
Meropenem
Origin:
EU

Meropenem Kalceks (Meropenem)

Meropenem, the active ingredient in Meropenem Kalceks, is a carbapenem presented as an injectable solution for intravenous use. It treats severe bacterial infections, including intra‑abdominal, urinary tract, respiratory, central nervous system infections and sepsis, in hospitalized patients and is commonly used in critical care settings.

GNH India supplies Meropenem Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and specialty clinics worldwide, ensuring quality‑assured products that meet European Union standards. The company adheres to strict Good Distribution Practice, provides temperature‑controlled logistics where required, and supports regulatory compliance for importers.

Manufacturer / TM Owner

Kalceks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Meropenem is a broad‑spectrum carbapenem antibiotic indicated for serious bacterial infections affecting various organ systems.
  • Complicated intra‑abdominal infections: effective in eradicating mixed aerobic and anaerobic pathogens.
  • Complicated urinary tract infections: achieves bacterial clearance in resistant Gram‑negative infections.
  • Nosocomial pneumonia: provides coverage against multidrug‑resistant organisms.
  • Meningitis: penetrates the cerebrospinal fluid to treat central nervous system infections.
  • Sepsis: rapidly reduces bacterial load in systemic infections.

How It Works

  • Meropenem binds with high affinity to penicillin‑binding proteins (PBPs) on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial cell lysis. Its broad spectrum includes many Gram‑negative, Gram‑positive and anaerobic organisms, and it resists most β‑lactamases.

Side Effects

Meropenem may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Nausea
  • Diarrhea
  • Rash or pruritus
  • Infusion site phlebitis
  • Elevated liver enzymes
  • Headache

Serious or Rare Side Effects

  • Seizures, especially in patients with renal impairment
  • Anaphylaxis or severe hypersensitivity reactions
  • Clostridioides difficile‑associated colitis
  • Neutropenia or agranulocytosis
  • Thrombocytopenia
  • Acute renal impairment

Precautions & Warnings

  • When using Meropenem, consider the following precautions to ensure safe administration.
  • Renal function: adjust dose in patients with impaired renal clearance.
  • Hypersensitivity: discontinue if signs of allergic reaction appear.
  • Seizure risk: monitor patients with central nervous system disorders.
  • Superinfection: be aware of the risk of secondary infections, including fungal overgrowth.
  • Pregnancy: use only if the potential benefit justifies the potential risk; category unknown.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Meropenem can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

  • Valproic acid: may increase risk of seizures.
  • Phenobarbital or phenytoin: may reduce meropenem plasma levels.
  • Aminoglycosides: additive nephrotoxicity.
  • Loop diuretics: increased risk of renal impairment.
  • Probenecid: may raise meropenem concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: may enhance anticoagulant effect.
  • Oral contraceptives: reduced hormonal efficacy.
  • Vancomycin: potential additive nephrotoxicity.
  • Ceftazidime: competitive binding may affect activity.
  • Immunosuppressants: monitor drug levels and organ function.

Frequently Asked Questions

Meropenem Kalceks is indicated for severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired (nosocomial) pneumonia, bacterial meningitis and sepsis. It is used in hospital settings where broad‑spectrum coverage is required.

Meropenem inhibits bacterial cell wall synthesis by binding to penicillin‑binding proteins, preventing the cross‑linking of peptidoglycan strands. This leads to loss of cell wall integrity, osmotic instability and ultimately bacterial cell death, covering many Gram‑negative, Gram‑positive and anaerobic organisms.

The dosage of Meropenem Kalceks is determined by the prescribing clinician based on the type and severity of infection, patient weight, renal function and local guidelines. Only a qualified healthcare professional should set the dosing regimen.

Safety data for Meropenem in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and under medical supervision.

To order, submit an enquiry on the Meropenem Kalceks product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Meropenem shares the carbapenem class’s broad‑spectrum activity and resistance to most β‑lactamases, similar to imipenem or ertapenem. Compared with imipenem, meropenem has a lower risk of seizures and does not require co‑administration of cilastatin, making it a preferred option in many severe infections.

Meropenem Kalceks should be stored at 2‑8 °C (refrigerated). Keep the product in its original packaging, protect it from light, and avoid freezing or shaking the solution. Proper cold‑chain handling is essential to maintain stability.

Meropenem Kalceks is administered intravenously by slow infusion, typically over 15‑30 minutes, under aseptic conditions. The exact infusion rate and duration are determined by the prescribing clinician based on the infection type and patient tolerance.

Serious risks include the potential for seizures, especially in patients with renal dysfunction or pre‑existing CNS disorders, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and significant renal impairment. Prompt medical attention is required if these events occur.

Patients with a known hypersensitivity to meropenem, other carbapenems, or any β‑lactam antibiotics should avoid this product. Caution is also advised for individuals with a history of seizures, severe renal impairment, or those receiving interacting medications that may increase toxicity.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT